annual cash & cash equivalents:
$1.12B-$186.32M(-14.23%)Summary
- As of today (September 14, 2025), LEGN annual cash & cash equivalents is $1.12 billion, with the most recent change of -$186.32 million (-14.23%) on December 31, 2024.
- During the last 3 years, LEGN annual cash & cash equivalents has risen by +$238.91 million (+27.03%).
- LEGN annual cash & cash equivalents is now -14.23% below its all-time high of $1.31 billion, reached on December 31, 2023.
Performance
LEGN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$967.64M-$37.81M(-3.76%)Summary
- As of today (September 14, 2025), LEGN quarterly cash & cash equivalents is $967.64 million, with the most recent change of -$37.81 million (-3.76%) on June 30, 2025.
- Over the past year, LEGN quarterly cash & cash equivalents has dropped by -$324.63 million (-25.12%).
- LEGN quarterly cash & cash equivalents is now -36.17% below its all-time high of $1.52 billion, reached on June 30, 2023.
Performance
LEGN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LEGN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | -25.1% |
| 3 y3 years | +27.0% | +23.3% |
| 5 y5 years | +605.3% | +51.6% |
LEGN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | +27.0% | -36.2% | +13.7% |
| 5 y | 5-year | -14.2% | +605.3% | -36.2% | +109.2% |
| alltime | all time | -14.2% | >+9999.0% | -36.2% | +507.9% |
LEGN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $967.64M(-3.8%) |
| Mar 2025 | - | $1.01B(-10.4%) |
| Dec 2024 | $1.12B(-14.2%) | $1.12B(-7.4%) |
| Sep 2024 | - | $1.21B(-6.1%) |
| Jun 2024 | - | $1.29B(-0.8%) |
| Mar 2024 | - | $1.30B(-0.5%) |
| Dec 2023 | $1.31B(+27.5%) | $1.31B(-8.1%) |
| Sep 2023 | - | $1.42B(-6.1%) |
| Jun 2023 | - | $1.52B(+78.1%) |
| Mar 2023 | - | $851.40M(-17.1%) |
| Dec 2022 | $1.03B | $1.03B(+30.9%) |
| Jun 2022 | - | $784.51M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $792.71M(-10.3%) |
| Dec 2021 | $883.84M(+74.6%) | $883.84M(+45.7%) |
| Sep 2021 | - | $606.54M(-12.5%) |
| Jun 2021 | - | $692.96M(+49.8%) |
| Mar 2021 | - | $462.55M(-8.6%) |
| Dec 2020 | $506.07M(+217.9%) | $506.07M(-12.2%) |
| Sep 2020 | - | $576.54M(-9.7%) |
| Jun 2020 | - | $638.21M(+158.7%) |
| Mar 2020 | - | $246.73M(+55.0%) |
| Dec 2019 | $159.18M(-26.5%) | $159.18M |
| Dec 2018 | $216.44M(>+9900.0%) | - |
| Dec 2017 | $2.12M | - |
FAQ
- What is Legend Biotech Corporation annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Legend Biotech Corporation?
- What is Legend Biotech Corporation annual cash & cash equivalents year-on-year change?
- What is Legend Biotech Corporation quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Legend Biotech Corporation?
- What is Legend Biotech Corporation quarterly cash & cash equivalents year-on-year change?
What is Legend Biotech Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of LEGN is $1.12B
What is the all time high annual cash & cash equivalents for Legend Biotech Corporation?
Legend Biotech Corporation all-time high annual cash & cash equivalents is $1.31B
What is Legend Biotech Corporation annual cash & cash equivalents year-on-year change?
Over the past year, LEGN annual cash & cash equivalents has changed by -$186.32M (-14.23%)
What is Legend Biotech Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LEGN is $967.64M
What is the all time high quarterly cash & cash equivalents for Legend Biotech Corporation?
Legend Biotech Corporation all-time high quarterly cash & cash equivalents is $1.52B
What is Legend Biotech Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, LEGN quarterly cash & cash equivalents has changed by -$324.63M (-25.12%)